Aeluma Announces Second Quarter Fiscal 2026 Financial Results

Rhea-AI Summary

Aeluma (NASDAQ: ALMU) reported Q2 fiscal 2026 results for the quarter ended December 31, 2025: revenue $1.3M, GAAP net loss $1.9M (−$0.11/share), adjusted EBITDA loss $0.917M, and cash $38.6M. The company reaffirmed fiscal 2026 revenue guidance of $4.0M–$6.0M and highlighted NASA and RFSUNY contract awards, manufacturing scale-up, expanded IP (35 patents issued/pending), new senior hire for go-to-market, and progress toward commercialization.

Positive

• Cash and cash equivalents of $38.6M at Dec 31, 2025
• GAAP net loss improved to $1.9M from $2.9M year-over-year
• Fiscal 2026 revenue guidance of $4.0M–$6.0M provides clear near-term target

Negative

• Quarterly revenue declined to $1.3M from $1.6M YoY (≈19% decrease)
• Adjusted EBITDA swung to a $917k loss from a $647k gain YoY
• GAAP net loss widened versus prior quarter to $1.9M from $1.5M due to higher personnel costs

News Market Reaction

+0.96%

7 alerts

+0.96% News Effect

+2.1% Peak Tracked

-13.6% Trough Tracked

+$3M Valuation Impact

$303M Market Cap

0.5x Rel. Volume

On the day this news was published, ALMU gained 0.96%, reflecting a mild positive market reaction. Argus tracked a peak move of +2.1% during that session. Argus tracked a trough of -13.6% from its starting point during tracking. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $3M to the company's valuation, bringing the market cap to $303M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Q2 FY2026 Revenue: $1.3M Q2 FY2025 Revenue: $1.6M GAAP Net Loss: $1.9M +5 more

8 metrics

Q2 FY2026 Revenue $1.3M Second quarter fiscal 2026; primarily from R&D contracts

Q2 FY2025 Revenue $1.6M Second quarter fiscal 2025 comparison

GAAP Net Loss $1.9M Q2 FY2026; ($0.11) per basic and diluted share

Adjusted EBITDA -$917K Q2 FY2026 adjusted EBITDA loss

Cash & Equivalents $38.6M Balance as of December 31, 2025

Cash Prior Period $15.7M Cash as of June 30, 2025

FY2026 Revenue Guidance $4.0M–$6.0M Full fiscal year 2026 expected revenue range

Target New Contracts 3–7 Planned new development contracts in fiscal 2026

Market Reality Check

Price: $15.38 Vol: Volume 723,371 is 1.72x t...

high vol

$15.38 Last Close

Volume Volume 723,371 is 1.72x the 20-day average of 419,398, indicating elevated interest ahead of/into the earnings release. high

Technical Price $16.79 is very close to the 200-day moving average at $16.67, suggesting a test of a key long-term level.

Peers on Argus

ALMU gained 11.61% while peers were mixed: WOLF rose 10.68% but VLN, MRAM, NA an...

ALMU gained 11.61% while peers were mixed: WOLF rose 10.68% but VLN, MRAM, NA and SQNS declined. The move appears company-specific rather than a broad semiconductor rotation.

Common Catalyst Only Wolfspeed (WOLF) had notable AI-related news today; other peers lacked similar catalysts, reinforcing that ALMU’s move tied mainly to its own earnings update.

Previous Earnings Reports

5 past events · Latest: Nov 12 (Positive)

Same Type Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Nov 12	Q1 FY26 earnings	Positive	-2.4%	Q1 FY2026 revenue growth, stronger liquidity, NASA contract and higher fabrication scale.
Sep 09	FY25 results	Positive	-27.5%	Q4 and FY2025 revenue surged to $4.7M with six government R&D contracts.
May 07	Q3 FY25 earnings	Positive	+7.2%	Strong Q3 FY2025 revenue, net income, uplisting, capital raise and DOE contract.
Feb 10	Q2 FY25 earnings	Positive	-6.0%	Record Q2 FY2025 revenue, raised guidance, NASA quantum contract, AIM Photonics join.
Nov 08	Q1 FY25 earnings	Positive	+3.3%	Record Q1 FY2025 revenue, narrowed net loss and strengthened cash via private offerings.

Pattern Detected

Earnings releases have often been fundamentally positive but produced mixed to negative next-day reactions, with more divergences than alignments.

Recent Company History

Recent Aeluma updates have centered on quarterly and annual results, with revenue climbing from $481K in Q1 FY2025 to $4.7M for FY2025 and continued FY2026 guidance of $4.0–$6.0M. Prior earnings highlighted NASA, DOE, and defense contracts, uplisting, and strengthened liquidity, yet price reactions skewed negative after several positive reports. Today’s Q2 FY2026 results and reiterated guidance fit this trajectory of scaling R&D contracts and commercialization efforts while investors reassess valuation and growth pacing.

Historical Comparison

earnings

-5.1 %

Average Historical Move

Historical Analysis

In the past five earnings releases, ALMU’s average next-day move was -5.09%. Today’s +11.61% reaction to Q2 FY2026 results stands out versus typically subdued or negative responses.

Typical Pattern

Earnings updates show Aeluma progressing from early revenue ramps in FY2025 to FY2026 guidance of $4.0–$6.0M, supported by expanding government R&D contracts and manufacturing scale.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2025-08-06

Aeluma has an active S-3/A shelf dated 2025-08-06, effective through 2028-08-06, with 6 recorded usage events including multiple 424B3 resale prospectuses. Recent filings on 2026-02-09 and earlier in late 2025 register shares for resale by existing stockholders, with the company stating it will not receive proceeds from those resales aside from potential warrant exercises.

Market Pulse Summary

This announcement details Q2 FY2026 results with revenue of $1.3M, primarily from R&D contracts, and...

Analysis

This announcement details Q2 FY2026 results with revenue of $1.3M, primarily from R&D contracts, and a GAAP net loss of $1.9M. Cash strengthened to $38.6M versus $15.7M mid‑year, while FY2026 revenue guidance remains $4.0–$6.0M. Management emphasized commercialization, new contracts, and expanded manufacturing and test capacity. Investors may watch execution on the 3–7 targeted new contracts, revenue mix evolution, and how active resale registrations intersect with ongoing growth plans.

Key Terms

adjusted ebitda, non-gaap, gaap, stock-based compensation, +4 more

8 terms

adjusted ebitda financial

"Adjusted EBITDA loss was $917 thousand, compared to a gain of $647 thousand"

Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.

non-gaap financial

"This press release includes and makes reference to certain non-GAAP financial measures."

Non-GAAP refers to financial measures that companies use to show their earnings or performance without including certain expenses or income that are often added back to give a different picture. It matters because it can make a company's results look better or more favorable, but it may also hide important costs, so investors need to look at both GAAP (official rules) and non-GAAP numbers to get a full understanding.

gaap financial

"GAAP net loss was $1.9 million, or ($0.11) per basic and diluted share"

GAAP, or Generally Accepted Accounting Principles, are a set of standardized rules and guidelines that companies follow when preparing their financial statements. They ensure consistency, transparency, and comparability across different companies, making it easier for investors to understand and compare financial information accurately. This helps investors make informed decisions based on trustworthy and uniform financial reports.

stock-based compensation financial

"due to higher salaries, stock-based compensation and employee benefits driven by new"

Stock-based compensation is when a company pays employees, directors or consultants with shares or the right to buy shares instead of or in addition to cash. It matters to investors because issuing stock or options spreads ownership thinner (like cutting a pie into more slices), which can reduce each existing share’s claim on profits and can also change reported earnings; investors watch it to assess true cost of running the business and how management is incentivized.

convertible notes financial

"amortization of discount on convertible notes, and changes in fair value"

Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.

derivative liabilities financial

"amortization of discount on convertible notes, and changes in fair value of derivative liabilities"

Derivative liabilities are obligations a company records when it owes money under financial contracts whose value depends on something else, like interest rates, stock prices, or currencies. Think of them as bets or insurance policies that can create future cash payments; they matter to investors because they can cause sudden changes in a company’s reported debt, profits and cash flow and reveal exposure to market risks that could affect valuation.

wafer probers technical

"we installed and commissioned automated wafer probers and other equipment to accelerate testing"

Wafer probers are specialized machines that electrically test semiconductor wafers by touching tiny contact points to check each chip’s functionality before they are cut and packaged. They matter to investors because they are critical capital equipment that affects manufacturing yield, product quality and production speed—much like a high-speed inspection station on a car assembly line that decides which parts move forward or get reworked, impacting costs and revenue timing.

silicon photonics technical

"RFSUNY aimed at integrating quantum dot lasers directly into the AIM Photonics 300mm silicon photonics platform."

Silicon photonics is the technology that uses tiny structures etched into silicon chips to generate, control and detect light for moving data and sensing, essentially putting optical fiber functions onto a computer chip. For investors, it matters because it can dramatically increase data speed and energy efficiency in data centers, telecom networks and advanced sensors, potentially lowering costs and enabling new products much like replacing many metal wires with faster, low-power optical highways.

AI-generated analysis. Not financial advice.

• Awarded NASA Contract for Quantum and RFSUNY Contract for Silicon Photonics Laser
• Recently Appointed Senior Vice President of Business Development and Product to Drive Go-to-Market Plan
• Cash and Cash Equivalents as of December 31, 2025 of $38.6 Million
  

GOLETA, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU) (“Aeluma” or the “Company”), a transformative semiconductor company specializing in high-performance and scalable technologies, today reported financial results for its second quarter of fiscal 2026 ended December 31, 2025.

Management Commentary

“The second quarter marked another big step forward for Aeluma as we gear up for commercialization,” said Jonathan Klamkin, Ph.D., Founder and CEO of Aeluma. “We ramped engagements across our target markets and increased visibility at a major industry conference. We are experiencing growing and sustained interest in Aeluma as our technology takes shape and market demand increases across mobile, data centers, and defense.”

“During the quarter, we continued to increase operations with foundry partners and are delighted with the performance, quality, and yield of wafers being tested at Aeluma’s facility,” Klamkin continued. “Relationships with customers and partners are strengthening, and we are fortunate that Bouch Nessar, our new Senior Vice President of Business Development and Product, has joined at this pivotal time to accelerate our go-to-market plan. Our IP portfolio also continues to expand, now counting 35 issued and pending patents, with our most recent application related to large-scale manufacturing of high-performance semiconductors.”

Klamkin concluded, “We are receiving increasing requests for price quotations and have begun taking sales orders. While these initial orders are relatively small in value, this marks an important milestone toward broader market adoption. As we move through fiscal 2026, we are intensely focused on commercialization and building long-term value.”

Recent Company Highlights

• Growing Market Traction and Visibility: Increased engagement with customers, partners, and government agencies, reflecting rising awareness of Aeluma’s scalable semiconductor platform across mobile and consumer electronics, data centers and AI infrastructure, and defense.
• Leadership and Team Expansion: Added experienced leadership and technical talent, including Bouchaib (Bouch) Nessar as Senior Vice President of Business Development and Product to drive go-to-market strategy, alongside other key hires in supply chain manufacturing, technology enablement, and engineering.
• Expanded Engagements with Manufacturing Partners: Continued to fabricate wafers with foundries to qualify Aeluma processes for key end markets. Strengthened relationships with manufacturing partners to accelerate transition to production.
• Bolstered Wafer-Scale Test and Validation Capabilities: Following our November asset acquisition announcement, we installed and commissioned automated wafer probers and other equipment to accelerate testing of semiconductor photonic components. This will help qualify foundry manufacturing processes for key target markets.
• Continued R&D Contracts Progress: Building on recently announced NASA contract for quantum, we received additional contract funding from RFSUNY aimed at integrating quantum dot lasers directly into the AIM Photonics 300mm silicon photonics platform. Also received several additional award notices, reinforcing customer confidence in Aeluma’s technology and supporting expectations for additional contracts this year.
• Consortium Membership Expands Defense and Commercial Footprint: Admitted to MMEC consortium during the quarter, strengthening Aeluma’s position within the defense and commercial ecosystem and enhancing access to government and defense opportunities.
• Industry Award Validation: Recipient of 2025 LEAP Award for Advanced Materials Innovation, recognizing Aeluma’s disruptive SWIR platform. Award highlights Aeluma’s competitive advantage in bridging high-performance sensing with scalable and mass-market semiconductor manufacturing.
• Visibility and Marketing at SPIE Photonics West: Presented a breakthrough paper on scalable 200mm silicon integration for quantum photonics and hosted exhibition booth with strong customer and partner engagement.
• Expanded Intellectual Property Portfolio: Increased total issued and pending patents to 35, with a recent filing focused on scalable, high-performance photonics for 3D imaging and data center applications.

Fiscal Q2 2026 Financial Results

• Revenue was $1.3 million compared to $1.6 million in the second quarter of 2025, and $1.4 million in the first quarter of 2025. Revenue in the quarter was primarily from R&D contracts.
• GAAP net loss was $1.9 million, or ($0.11) per basic and diluted share, compared to a net loss of $2.9 million, or ($0.24) per basic and diluted share, for the same period last year and net loss of $1.5 million, or ($0.09) per basic and diluted share, in the prior quarter. GAAP net loss increased from the prior quarter primarily due to higher salaries, stock-based compensation and employee benefits driven by new employee hires to support the expansion of the business and scaling of operations.
• Adjusted EBITDA loss was $917 thousand, compared to a gain of $647 thousand in the same period last year, and a loss of $450 thousand in the prior quarter. Adjusted EBITDA loss increased year over year and quarter over quarter primarily due to higher salaries, stock-based compensation and employee benefits for new employee hires.
• Cash and cash equivalents totaled $38.6 million at December 31, 2025, compared to $15.7 million at June 30, 2025.

Fiscal Year 2026 Guidance and Strategic Priorities

For the full fiscal year of 2026, based on current and anticipated market conditions, Aeluma continues to expect revenue in a range of $4.0 million to $6.0 million. The following reaffirms the Company’s strategic priorities for 2026:

• New Contract Wins: Three to seven new development contracts, which provide non-dilutive funding for R&D investments and the growth of partnership opportunities.
• Team Expansion: Growth of our business development and go-to-market team, technical leadership and staff, and operations team.
• Enhanced Manufacturing Readiness: Increased outsourced wafer manufacturing productivity. Expanded test and validation capabilities, technology qualification for targeted industries, and supply chain partnerships.
• Go-to-Market Traction: Product roadmap being driven by continued progress in target commercial markets across mobile and consumer electronics, photonics for AI infrastructure, and defense and aerospace.

Conference Call and Webcast

Aeluma will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on February 11, 2026, to discuss the Company’s financial results and business outlook. Interested participants may access the conference the call by dialing (877) 317-6789 (domestic) or (412) 317-6789 (international) and referencing “Aeluma.”

A live webcast of the call will be available on the “Investors” section of Aeluma’s website and can also be accessed by clicking here. A replay of the conference call will be available on Aeluma’s website shortly after the call concludes.

Note about Non-GAAP Financial Measures

This press release includes and makes reference to certain non-GAAP financial measures. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Aeluma believes that the presentation of non-GAAP financial measures provides important supplemental information to management and investors regarding financial and business trends relating to the Company's financial condition and results of operations. Aeluma believes that these non-GAAP financial measures provide additional insight into Aeluma's ongoing performance and core operational activities and has chosen to provide these measures for more consistent and meaningful comparison between periods. These measures should only be used to evaluate Aeluma's results of operations in conjunction with the corresponding GAAP measures. The non-GAAP results exclude the effect of stock-based compensation, depreciation and amortization.

This press release includes non-GAAP financial measures, including:

• Non-GAAP net income (loss), which is defined as GAAP net income (loss) plus stock-based compensation expenses, amortization of discount on convertible notes, and changes in fair value of derivative liabilities; and
• Adjusted EBITDA, defined as non-GAAP net income (loss) plus depreciation and amortization expenses, less interest income.

A reconciliation between GAAP and non-GAAP financial results is provided in the financial statements portion of this press release.

Forward-Looking Statements

All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the Company's expectations regarding its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors. These statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expect,” “intend,” “plan,” “project,” “believe,” “estimate,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company's control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.

About Aeluma, Inc.

Aeluma (NASDAQ: ALMU) is a transformative semiconductor company specializing in high-performance photonic and electronic technologies that scale. The company’s proprietary platform combines compound semiconductors with scalable manufacturing used for mass market microelectronics to enable volume production and large-scale integration. Applications for Aeluma’s technology include mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum. Headquartered in Goleta, California, Aeluma operates state-of-the-art R&D and manufacturing capabilities for semiconductor wafer production, quick-turn chip fabrication, rapid prototyping, test and validation. Aeluma also partners with production-scale fabrication foundries, packaging, and integration companies. For more information, visit www.aeluma.com.

Company:

Aeluma, Inc.
(805) 351-2707
info@aeluma.com

Investor Contact:

Financial Profiles, Inc.
Moira Conlon & Alex Villalta
(310) 622-8227
ir@aeluma.com

Aeluma, Inc. and Subsidiary
Condensed Consolidated Balance Sheets

($ in thousands)		December 31, 2025 (unaudited)				June 30, 2025
Assets
Current assets:
Cash and cash equivalents		$	38,572			$	3,628
Certificate of deposit							12,112
Accounts receivable			1,000				962
Prepaids and other current assets			691				633
Total current assets			40,263				17,335
Property and equipment:
Equipment			1,933				1,692
Leasehold improvements			547				547
Accumulated depreciation			(1,229	)			(1,021	)
Property and equipment, net			1,251				1,218
Right of use asset - operating			1,033				836
Other assets			23				17
Total assets		$	42,570			$	19,406
Liabilities and stockholders' equity
Current liabilities:
Accounts payable		$	184			$	361
Accrued expenses and other current liabilities			449				206
Lease liability - operating, current portion			192				138
Total current liabilities			825				705
Lease liability - operating, long-term portion			942				803
Total liabilities			1,767				1,508
Commitments and contingencies			-				-
Stockholders’ equity:
Preferred stock			-				-
Common stock			2				2
Additional paid-in capital			60,793				34,542
Accumulated deficit			(19,992	)			(16,646	)
Total stockholders’ equity			40,803				17,898
Total liabilities and stockholders’ equity		$	42,570			$	19,406

Aeluma, Inc. and Subsidiary
Condensed Consolidated Statements of Operations (unaudited)

		Three Months Ended												Six Months Ended
($ in thousands, except per share data)		December 31, 2025				September 30, 2025				December 31, 2024				December 31, 2025				December 31, 2024
Revenue		$	1,272			$	1,385			$	1,612			$	2,657			$	2,093
Operating expenses:
Cost of goods sold			919				701				584				1,620				899
Research and development							606				268				1,512				669
General and administrative			1,528				1,686				371				3,214				867
Total operating expenses			3,353				2,993				1,223				6,346				2,435
Income (loss) from operations			(2,081	)			(1,608	)			389				(3,689	)			(342	)
Other income (expense):
Interest income			228				115				-				343				-
Amortization of discount on convertible notes			-				-				(283	)			-				(428	)
Changes in fair value of derivative liabilities			-				-				(3,001	)			-				(2,855	)
Total other income (expense), net			228				115				(3,284	)			343				(3,283	)
Loss before income tax expense			(1,853	)			(1,493	)			(2,895	)			(3,346	)			(3,625	)
Income tax expense			-				-				-				-				-
Net loss		$	(1,853	)		$	(1,493	)		$	(2,895	)		$	(3,346	)		$	(3,625	)
Net loss per share – basic and diluted		$	(0.11	)		$	(0.09	)		$	(0.24	)		$	(0.20	)		$	(0.30	)
Weighted average common shares outstanding – basic and diluted			17,875,930				16,141,153				12,212,403				17,008,544				12,195,415
Book value per share		$	2.28			$	2.53			$	(0.08	)		$	2.28			$	(0.08	)

Aeluma, Inc. and Subsidiary
Condensed Consolidated Statements of Cash Flows (unaudited)

		Six Months Ended December 31,
($ in thousands)		2025				2024
Operating activities:
Net loss		$	(3,346	)		$	(3,625	)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of deferred compensation			-				14
Stock-based compensation expense			2,112				316
Depreciation and amortization expense			210				202
Amortization of discount on convertible notes			-				428
Changes in fair value of derivative liabilities			-				2,855
Changes in operating assets and liabilities:
Accounts receivable			(38	)			(1,265	)
Prepaids and other current assets			(58	)			(114	)
Other assets			(8	)				-
Accounts payable			(177	)			(134	)
Accrued expenses and other current liabilities			239				(9	)
Net cash used in operating activities			(1,066	)			(1,332	)
Investing activities:
Purchase of equipment			(241	)			(41	)
Net cash used in investing activities			(241	)			(41	)
Financing activities:
Proceeds from stock option exercise			64				-
Proceeds from stock warrant exercise			690				-
Proceeds from convertible notes issuance			-				3,145
Proceeds from public offering, net of offering costs			23,385				-
Net cash provided by financing activities			24,139				3,145
Net change in cash and cash equivalents, and certificate of deposit			22,832				1,772
Cash and cash equivalents, and certificate of deposit, beginning of period			15,740				1,291
Cash and cash equivalents, and certificate of deposit, end of period		$	38,572			$	3,063
Supplemental non-cash disclosures:
Right of use asset - operating obtained in exchange for lease liability - operating		$	274				-

Aeluma, Inc. and Subsidiary
Reconciliation of GAAP and Non-GAAP Financial Measures (unaudited)

		Three Months Ended												Six Months Ended
($ in thousands, except per share data)		December 31, 2025				September 30, 2025				December 31, 2024				December 31, 2025				December 31, 2024
GAAP net loss		$	(1,853	)		$	(1,493	)		$	(2,895	)		$	(3,346	)		$	(3,625	)
Non-GAAP adjustments:
Stock-based compensation - stock option			1,056				1,056				149				2,112				316
Consulting and advisory - restricted stock award			-				-				7				-				14
Amortization of discount on convertible notes			-				-				283				-				428
Changes in fair value of derivative liabilities			-				-				3,001				-				2,855
Total adjustments to GAAP net loss			1,056				1,056				3,440				2,112				3,613
Non-GAAP net income (loss)		$	(797	)		$	(437	)		$	545			$	(1,234	)		$	(12	)
Depreciation & amortization			108				102				102				210				202
Interest income			(228	)			(115	)			-				(343	)			-
Adjusted EBITDA		$	(917	)		$	(450	)		$	647			$	(1,367	)		$	190
GAAP net loss per share – basic and diluted		$	(0.11	)		$	(0.09	)		$	(0.24	)		$	(0.20	)		$	(0.30	)
Non-GAAP adjustments			0.07				0.06				0.28				0.13				0.30
Non-GAAP net income (loss) per share – basic and diluted		$	(0.04	)		$	(0.03	)		$	0.04			$	(0.07	)		$	-

FAQ

What were Aeluma (ALMU) Q2 fiscal 2026 revenue and net loss figures?

Aeluma reported Q2 revenue of $1.3M and a GAAP net loss of $1.9M (−$0.11/share). According to the company, revenue was primarily from R&D contracts and results reflect early commercialization stage and increased operating hires.

How much cash did Aeluma (ALMU) hold at December 31, 2025 and what does that mean for runway?

Aeluma held $38.6M in cash and cash equivalents at Dec 31, 2025. According to the company, the cash build versus $15.7M at June 30, 2025 supports near-term commercialization and operational expansion plans.

What is Aeluma's fiscal 2026 revenue guidance for ALMU and its significance?

Aeluma expects fiscal 2026 revenue of $4.0M–$6.0M. According to the company, this range reflects anticipated R&D contract wins, scaled manufacturing engagements, and early product orders as commercialization progresses.

Why did Aeluma's adjusted EBITDA swing to a loss in Q2 2026 for ALMU?

Adjusted EBITDA was a $917k loss in Q2, versus a prior-year gain. According to the company, the swing resulted primarily from higher salaries, stock-based compensation, and employee benefits tied to recent hires.

What do the NASA and RFSUNY contract awards mean for Aeluma (ALMU)'s commercialization?

The NASA and RFSUNY awards support technology integration and development for quantum and silicon photonics. According to the company, these contracts advance manufacturing qualification, strengthen customer validation, and may lead to additional funded development work.